University of Adelaide
The current economic model (where sales volumes and price determine the return on investment for a drug) does not foster appropriate antimicrobial use. Financial risks associated with antimicrobial resistance has resulted in a decline in the marketing of new drugs & insecurity of supply of current antimicrobials. This project is focused on the Australian market within a global context.
Edits to this activity are currently being reviewed. If you want to update or request removal please email email@example.com.